NON-IMMUNOGENIC PROTEIN NANOPARTICLES WITH CANCER TARGETING ACTIVITY USING ABMUMIN-BINDING PEPTIDE

    公开(公告)号:US20200181204A1

    公开(公告)日:2020-06-11

    申请号:US16663651

    申请日:2019-10-25

    Abstract: The present invention relates to recombinant self-assembling protein nanoparticles presenting an albumin-binding peptide at the surface. For the recombinant self-assembling protein nanoparticles according to the present invention, an albumin-binding peptide can reduce the immunogenicity of the recombinant self-assembling protein nanoparticles because the albumin-binding peptide is presented at the surface, and thus binds to an albumin protein present in vivo, and the albumin-binding peptide can also provide the cancer delivery function of the recombinant self-assembling protein nanoparticles because the albumin-binding peptide binds to albumin around cancer. Simultaneously, the binding of the albumin-binding peptide to albumin can significantly increase the in vivo residence time of the recombinant self-assembling protein nanoparticles, thus increasing the potential for use in various medical applications.

Patent Agency Ranking